1608 WALNUT ST STE 1600 PHILADELPHIA, PA 19103 Get Directions
1608 WALNUT ST STE 1600 PHILADELPHIA, PA 19103 Get Directions
Founded 2011
Incorporated PA
Annual Revenue $98,000.00
Employee Count 1
Industries Pharmaceutical Preparations
Contacts Anthony Mack ProSolus Pharmaceuticals LP targets opportunities to formulate high barrier to entry generic Transdermal Drug Delivery systems (TDDs), with a strategic focus on generic ANDA and 505(b)(2) applications. ProSolus develops transdermal products at our state of the art laboratory as well as in-license TDDs that meet strict criteria. We have strategic alliances to provide pilot, clinical supply and commercial volumes to the market providing product under strict cGMP and as required DEA compliance. Our strategic partners have excellent FDA track records with no 483's over the past decade of inspections.
Our Goals:
Formulate, Develop, and Out-license TDDs in the U. S. and Internationally.
Provide resources and technical support through commercialization.
Enter into Agreements on a cost/profit sharing basis to commercialize TDDs.
Offer Fee for Service development of TDDs identified by ProSolus.
Collaborate to provide full or supplemental services to assure speed to market.
VERIFIED Status:
UNVERIFIED
Address:
LAST VERIFIED:
--
Phone:
Payment Method:
Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.
Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.